BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2007
View Archived Issues
Novel treatments for inflammatory disorders claimed in recent patents
Read More
Transdermal lisuride and oral ropinirole compared in restless legs syndrome trial
Read More
Study finds little effect of modafinil on fatigue related to Parkinson's disease
Read More
Phase I study of AMR-001 for myocardial infarction progresses
Read More
mAb-216 studied in B-lineage acute lymphoblastic leukemia patients
Read More
Bcr-Abl(T315I) drug-resistant clones are fully suppressed by combination therapy
Read More
Dainippon presents six-month ended September 30, 2007 results
Read More
Novel agents for gastrointestinal disorders reported in recent patents
Read More
FDA grants orphan drug designation to Celldex for CDX-110
Read More
Discovery of novel analgesic agents described in recent patent literature
Read More
Sequoia Pharmaceuticals submits IND application for SPI-452
Read More
Lexicon initiates phase IIa trial of LX-6171 for cognitive disorders
Read More
Speedel initiates phase IIa clinical trial of SPP-635 in diabetic patients with hypertension
Read More
DSMB recommends continuation of TRIST clinical trial of Oxford BioMedica's TroVax
Read More
Pfizer initiates phase I clinical trial of Rigel's R-343 for allergic asthma
Read More
Genmab initiates phase I/II study of HuMax-CD38 for multiple myeloma
Read More
Eisai acquires MGI Pharma for approximately USD 3.9 billion
Read More
FDA grants fast track designation to Osiris' Prochymal for acute GVHD
Read More
Novel V1a/V2 vasopressin receptor antagonist selected as a clinical candidate
Read More
Preclinical activity of OT-304 against chemotherapy-resistant tumors
Read More
Neurotrophic-expressing AAV vectors improve symptoms in mouse model of ALS
Read More
Mologen submits clinical study application for dSLIM for the treatment of cancer
Read More
Galapagos and GSK enter strategic alliance to develop novel antibacterials and antivirals
Read More
DOR BioPharma seeks approval for orBec NDA
Read More
ImmuPharma initiates phase IIb trials for IPP-201101 for systemic lupus erythematosus
Read More
Serenex initiates phase I trial of SNX-5422 for hematological malignancies
Read More
SymBio initiates phase II clinical study of bendamustine hydrochloride
Read More
FDA issues approvable letter for GSK's Requip XL for idiopathic Parkinson's disease
Read More